Supply Chain | August 31, 2024
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
EBITDA grew by 31% YoY with EBITDA margin of 11%, a YoY improvement of over 170bps vs. Q1FY24
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
EBITDA before special items falls 1.3 percent to € 4.41 billion
Around 7% of the Indian population suffers from IBS
CHL is strengthening its play in the fast-growing beauty and personal care sector
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Subscribe To Our Newsletter & Stay Updated
